Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ona domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/risezcom/public_html/cord-blood.org.uk/wp-includes/functions.php on line 6170
Study Finds Umbilical Cord Stem Cells With Enhanced Homing Ability Can Repair Lung Damage - Cord Blood

Cord Blood

and Stem Cell Banking

Study Finds Umbilical Cord Stem Cells With Enhanced Homing Ability Can Repair Lung Damage

A scientist looking at graphs on a computer screen

Acute respiratory distress syndrome (ARDS) is a severe condition that causes breathing difficulties and low oxygen levels in the blood. It can lead to pulmonary fibrosis, a condition where scar tissue forms in the lungs and makes breathing challenging. Unfortunately, there is no effective treatment for ARDS-induced pulmonary fibrosis. However, a promising study suggests that umbilical cord stem cells can be a potential solution.

The Study

Scientists conducted a study to investigate if umbilical cord stem cells with enhanced homing ability could effectively repair lung damage caused by ARDS. They built a lentiviral vector to overexpress a molecule called CXCR7 in the stem cells. CXCR7 helps the stem cells find their way to the site of injury. The researchers then tested the effects of these enhanced stem cells in a mouse model of ARDS.

Findings

The study found that the effectiveness of the stem cells in repairing lung damage was directly related to the amount of CXCR7 expression and the duration of treatment. The stem cells with increased CXCR7 expression showed improved proliferation and migration of lung epithelial cells. The overexpression of CXCR7 also inhibited the production of fibrosis-related proteins, suggesting that it could alleviate pulmonary fibrosis caused by ARDS.

Mechanism

Further investigations revealed that CXCR7 works by suppressing a signaling pathway called Wnt/β-catenin, which is linked to fibrosis. This suppression inhibits the activity of another protein called Jag1, which is involved in fibrosis development. By blocking Jag1, CXCR7 helps prevent the progression of pulmonary fibrosis.

Conclusion

This groundbreaking study demonstrates that umbilical cord stem cells with enhanced CXCR7 expression can effectively repair lung damage caused by ARDS. The findings also shed light on the mechanism behind the stem cells’ therapeutic effect. This research brings us one step closer to developing new and effective treatments for ARDS-induced pulmonary fibrosis, improving the prognosis and quality of life for patients.